Genetic animal models of schizophrenia related with the hypothesis of abnormal neurodevelopment.

Lingling Lu, Takayoshi Mamiya, Takenao Koseki, Akihiro Mouri, Toshitaka Nabeshima

The Academic Frontier Project for Private University, Comparative Cognitive Science Institute, Meijo University, Japan.

Journal Article: Biological & Pharmaceutical Bulletin (impact factor: 1.81). 01/2011; 34(9):1358-63.

Abstract

Accumulating evidence supports the existence of an overlap in genetic susceptibility with schizophrenia. Translation of human genetic mutations into animals is one of the most important strategies to study the pathogenesis of schizophrenia, identify potential drug targets, and test new medicines for antipsychotic treatment. Recent discoveries of susceptibility genes for schizophrenia make the possibility to develop newer genetic mouse models based on the neurodevelopmental hypotheses of schizophrenia. Although it is not possible to mimic all schizophrenic symptoms by these animal models, the genetic mouse models based on the neurodevelopmental hypothesis are widely developed to reproduce several schizophrenia-like behavioral and biochemical changes in humans. In this mini review, we will discuss the neuropathological and behavioral manifestations of representative genetic mouse models for schizophrenia, associated with the hypothesis of abnormal neurodevelopment.

Source: PubMed

Comments on this publication

ResearchGate members can add comments. Sign up now and post your comment!

Similar publications

Science & Research Jobs

Keywords

Accumulating evidence
 
biochemical changes
 
genetic mouse models
 
genetic susceptibility
 
human genetic mutations
 
mimic
 
mini review
 
neurodevelopmental hypotheses
 
neurodevelopmental hypothesis
 
newer genetic mouse models
 
pathogenesis
 
potential drug targets
 
Recent discoveries
 
representative genetic mouse models
 
schizophrenic symptoms
 
susceptibility genes
 
test new medicines